PCYC

Pharmacyclics, Inc. News Headlines

$140.33
*  
1.81
1.31%
Get PCYC Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PCYC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Biotech: And Yet We've Just Begun...
11/14/2014 10:06:21 AM - Martin Tillier


Stocks Fluctuating As Traders Digest Mixed Jobs Data - U.S. Commentary
11/7/2014 12:10:00 PM - RTT News


Interest Rate Concerns Contribute To Weakness On Wall Street - U.S. Commentary
11/7/2014 10:05:00 AM - RTT News


Biotech Watchlist Update: Small-Cap Biotechs Struggle, But Investors Remain Enchanted By Big Pharma's Returns
11/7/2014 9:16:00 AM - Seeking Alpha


Pharmacyclics Tops Q3 Earnings, Ties Up with AstraZeneca - Analyst Blog
11/5/2014 12:00:00 PM - Zacks.com


Pharmacyclics Results Top Estimate
11/4/2014 7:15:00 PM - RTT News


Earnings Reaction History: Pharmacyclics Inc., 62.5% Follow-Through Indicator, 4.8% Sensitive
11/4/2014 2:59:24 PM - MT Newswires


After-Hours Earnings Report for November 4, 2014 : FOXA, PXD, FOX, DVN, ATVI, SBAC, PBA, OKE, TRIP, JAZZ, PCYC, XEC
11/4/2014 2:00:03 PM - NASDAQ.com News


The Time Is Now For Northwest Biotherapeutics
10/29/2014 3:16:00 PM - Seeking Alpha


Buy These 5 Breakout Health Care Stocks for Healthy Gains
10/28/2014 10:30:00 AM - TheStreet


Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog
10/22/2014 12:54:00 PM - Zacks.com


NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal
10/20/2014 11:47:00 PM - RTT News


Sector Update: Health Stocks Higher Pre-Bell
10/20/2014 7:54:23 AM - MT Newswires


Sector Update: Health Care
10/20/2014 7:53:17 AM - MT Newswires


Pharmacyclics, Roche Ink Deal for Cancer Combo Therapy - Analyst Blog
10/17/2014 5:15:00 PM - Zacks.com


IMBRUVICA Gets Marketing Approval From EC For Treatment Of Two Blood Cancers
10/17/2014 9:14:00 AM - RTT News


Sector Update: Health Stocks Higher Pre-Bell
10/17/2014 8:21:20 AM - MT Newswires


Sector Update: Health Care
10/17/2014 8:19:42 AM - MT Newswires


AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche
10/17/2014 12:53:00 AM - RTT News


Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg
10/15/2014 7:45:02 AM - Motley Fool


Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog
10/14/2014 4:20:00 PM - Zacks.com


Interesting PCYC Put And Call Options For January 2017
10/13/2014 10:56:47 AM - BNK Invest


Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
10/13/2014 8:28:00 AM - RTT News


15 Surprising Cancer Statistics
10/12/2014 8:41:02 AM - Motley Fool


Stocks Under Pressure Amid Global Economic Concerns - U.S. Commentary
10/7/2014 10:25:00 AM - RTT News